The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.